Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
FAAH inhibitor.
Ca2+-sensing receptor agonist.
p110β PI3K inhibitor.
Triterpene saponin found in species of Panax; 2...
Antimicrobial peptide found in amphibians.
Geldanamycin derivative; HSP90 inhibitor.
2-methyl-1,4-naphthoquinone derivative
Impurity of everolimus
Bone deterioration inhibitor, potential CaR ago...
Chloramphenicol derivative; protein translation...
CD73 inhibitor
Polyether pyrrole, divalent cation ionophore.
Flavanol originally found in Camilla (green tea...
Phenylpyrazoleanilide; IL-17 production inhibit...
Purine derivative; CDK inhibitor.
Flavonoid found in Epimedium.
Peptide; NMDA partial agonist.
EGFR inhibitor.